The Gelb Center provides top-level service to identify and fulfill an investigator's needs on an individual and customized basis. Custom protocols for prospective collections may also be developed per an investigator's specifications. Clinical data and biospecimens are available from patients with GU cancers such as prostate, kidney, and bladder cancers.
De-identified clinical data available in our Clinical Research Information System (CRIS) databases include:
- Demographic data (age, race/ethnicity)
- GU cancer-related treatment history
- Scan results
- PSA results (for prostate cancer only)
- Cause of death
Additional clinical data may be available per investigator's specifications.
Blood specimen types include:
Prospective collection may be feasible per your specific requirements.
Formalin-fixed, paraffin-embedded (FFPE) tissues are currently available. Tissue microarrays (TMAs), frozen tissue and fresh tissue may be obtained per your specific requirements.